Press Releases Archives - Page 2 of 2

CXD101 update presented at Inaugural Meeting of Oxford Centre for Cancer Gene Research

by madewithjoy on April 18, 2017 with No Comments

Download as a PDFOxford 12 April 2017; Celleron Therapeutics Limited, the UK based precision cancer medicines company, developing novel small molecule therapeutics, announced today that research on CXD101 its novel dual action HDAC inhibitor had been presented at the Inaugural … Read More

Celleron Therapeutics announces completion of a new funding round with international investors

by madewithjoy on January 31, 2017 with No Comments

Download as a PDFOxford 31st January 2017; Celleron Therapeutics Limited, the UK-based precision cancer medicines company, focussed on clinical trials of novel small molecule therapeutics, announced today that it has completed a new financing round with a consortium of South … Read More

Celleron Therapeutics announces encouraging clinical results with its new cancer drug CXD101 in heavily pre-treated unresponsive cancer patients

by madewithjoy on December 1, 2015 with No Comments

Download as a PDFOxford, UK, 1st December 2015; Celleron Therapeutics, the UK-based company developing personalised medicine for cancer patients, has today announced that significant clinical activity was observed in the first human trial of its pioneering personalised cancer treatment CXD101 … Read More